Clinical study on mpMRI/TRUS software fusion-guided transperineal prostate biopsy
| Title: | Clinical study on mpMRI/TRUS software fusion-guided transperineal prostate biopsy |
|---|---|
| Authors: | Chen Ying, Yongbo Wang, Jianping Wang, Minghuang Rao, Chao Li, Yongchao Wang, Yujian Huang |
| Source: | Journal of Men's Health, Vol 21, Iss 1, Pp 81-86 (2025) |
| Publisher Information: | MRE Press, 2025. |
| Publication Year: | 2025 |
| Collection: | LCC:Medicine (General) |
| Subject Terms: | multiparametric magnetic resonance imaging, transrectal ultrasound, transperineal prostate biopsy, prostate cancer, Medicine (General), R5-920 |
| More Details: | Background: To enhance prostate cancer diagnosis, multiparametric Magnetic Resonance Imaging (mpMRI) combined with Transrectal Ultrasound (TRUS) fusion-guided biopsy has emerged as a promising technique. This study aimed to evaluate its clinical benefits over traditional TRUS-guided biopsy. Methods: A retrospective analysis was performed on 83 patients diagnosed between January 2022 and April 2024. Patients were divided into two groups: 41 underwent mpMRI/TRUS fusion-guided biopsy, while 42 had traditional TRUS-guided biopsy. The baseline characteristics of both groups were similar, facilitating a direct comparison of diagnostic efficacy and complication rates. Results: The fusion-guided group showed a significantly higher detection rate of clinically significant prostate cancer (21/41 vs. 12/42, p = 0.035). It also detected more clinically significant cases (20/41 vs. 11/42, p = 0.033). Notably, the fusion group experienced fewer complications, including no instances of hematochezia (p = 0.003) or infections (p = 0.012), and reported lower postoperative pain levels (Visual Analog Scale score 1.8 ± 0.78 vs. 2.33 ± 1.07, p = 0.012). Conclusions: The integration of mpMRI with TRUS in fusion-guided biopsy enhances the accuracy of detecting clinically significant prostate cancer, reduces procedural complications, and minimizes patient discomfort. This approach represents a significant advancement in prostate cancer management, improving both diagnostic outcomes and patient safety. |
| Document Type: | article |
| File Description: | electronic resource |
| Language: | English |
| ISSN: | 1875-6867 1875-6859 |
| Relation: | https://oss.jomh.org/files/article/20250124-466/pdf/JOMH2024081401.pdf; https://doaj.org/toc/1875-6867; https://doaj.org/toc/1875-6859 |
| DOI: | 10.22514/jomh.2025.008 |
| Access URL: | https://doaj.org/article/772666beebbb45e1a3220bfa52653039 |
| Accession Number: | edsdoj.772666beebbb45e1a3220bfa52653039 |
| Database: | Directory of Open Access Journals |
| ISSN: | 18756867 18756859 |
|---|---|
| DOI: | 10.22514/jomh.2025.008 |
| Published in: | Journal of Men's Health |
| Language: | English |